Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Buys 20,000 Shares

Retractable Technologies, Inc. (NYSE:RVPGet Free Report) CEO Thomas J. Shaw acquired 20,000 shares of the firm’s stock in a transaction on Tuesday, May 21st. The stock was purchased at an average cost of $0.90 per share, for a total transaction of $18,000.00. Following the completion of the acquisition, the chief executive officer now owns 14,442,749 shares in the company, valued at $12,998,474.10. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.

Retractable Technologies Stock Up 2.9 %

Shares of RVP traded up $0.03 during mid-day trading on Thursday, reaching $0.94. 34,745 shares of the company were exchanged, compared to its average volume of 81,705. Retractable Technologies, Inc. has a 52 week low of $0.87 and a 52 week high of $1.34. The company has a debt-to-equity ratio of 0.01, a current ratio of 11.02 and a quick ratio of 8.18. The business has a 50 day simple moving average of $1.10 and a two-hundred day simple moving average of $1.14.

Retractable Technologies (NYSE:RVPGet Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 7.55% and a negative net margin of 18.84%. The company had revenue of $7.60 million during the quarter.

Wall Street Analyst Weigh In

Separately, started coverage on Retractable Technologies in a report on Sunday. They set a “hold” rating on the stock.

Check Out Our Latest Stock Analysis on RVP

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

See Also

Insider Buying and Selling by Quarter for Retractable Technologies (NYSE:RVP)

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with's FREE daily email newsletter.